ClearPoint Neuro (CLPT) FCF Margin (2011 - 2026)
ClearPoint Neuro (CLPT) reported FCF Margin of 71.01% for Q1 2026, up 389.0% on a YoY basis from 14.52% in Q1 2025, and up 39.15% sequentially from 116.71% in Q4 2025.
ClearPoint Neuro (CLPT) FCF Margin (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of FCF Margin data on file, last reported at 71.01% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 389.0% year-over-year to 71.01%; the trailing twelve-month figure through Mar 2026 stood at 65.69% (down 2927.0% YoY), and the FY2025 full-year result was 66.06%, down 3667.0% from the prior year.
- FCF Margin climbed to 71.01% in Q1 2026, from 116.71% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 14.91% in Q3 2024 to a low of 116.71% in Q4 2025.
- A 5-year average of 59.82% and a median of 59.99% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin soared 5682 bps in 2024 and sank 9733 bps in 2025, its largest moves.
- Tracing CLPT's FCF Margin over 5 years: stood at 59.99% in 2022, then jumped by 71 bps to 17.47% in 2023, then fell by 11 bps to 19.38% in 2024, then tumbled by 502 bps to 116.71% in 2025, then jumped by 39 bps to 71.01% in 2026.
- Business Quant data shows CLPT's FCF Margin at 71.01% in Q1 2026, 116.71% in Q4 2025, and 37.23% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -71.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.01% |
| Dec 31, 2025 | -116.71% |
| Sep 30, 2025 | -37.23% |
| Jun 30, 2025 | -28.42% |
| Mar 31, 2025 | -74.90% |
| Dec 31, 2024 | -19.38% |
| Sep 30, 2024 | -14.91% |
| Jun 30, 2024 | -33.95% |
| Mar 31, 2024 | -50.27% |
| Dec 31, 2023 | -17.47% |
| Sep 30, 2023 | -35.25% |
| Jun 30, 2023 | -90.72% |
| Mar 31, 2023 | -107.09% |
| Dec 31, 2022 | -59.99% |
| Sep 30, 2022 | -76.20% |
| Jun 30, 2022 | -97.25% |
| Mar 31, 2022 | -86.23% |
| Dec 31, 2021 | -83.84% |
| Sep 30, 2021 | -74.79% |
| Jun 30, 2021 | -107.91% |